CA2954545A1 - Amphiphilic peptide nanoparticles for use as hydrophobic drug carriers and antibacterial agents - Google Patents

Amphiphilic peptide nanoparticles for use as hydrophobic drug carriers and antibacterial agents Download PDF

Info

Publication number
CA2954545A1
CA2954545A1 CA2954545A CA2954545A CA2954545A1 CA 2954545 A1 CA2954545 A1 CA 2954545A1 CA 2954545 A CA2954545 A CA 2954545A CA 2954545 A CA2954545 A CA 2954545A CA 2954545 A1 CA2954545 A1 CA 2954545A1
Authority
CA
Canada
Prior art keywords
hydrophobic
nanoparticles
carrier formulation
amphiphilic peptide
curcumin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2954545A
Other languages
English (en)
French (fr)
Inventor
Run CHANG
Linlin SUN
Thomas Jay Webster
Gujie MI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northeastern University
Original Assignee
Northeastern University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northeastern University filed Critical Northeastern University
Publication of CA2954545A1 publication Critical patent/CA2954545A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/0279—Porous; Hollow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/18—Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Composite Materials (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA2954545A 2014-07-08 2015-07-08 Amphiphilic peptide nanoparticles for use as hydrophobic drug carriers and antibacterial agents Abandoned CA2954545A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462021857P 2014-07-08 2014-07-08
US62/021,857 2014-07-08
PCT/US2015/039599 WO2016007664A1 (en) 2014-07-08 2015-07-08 Amphiphilic peptide nanoparticles for use as hydrophobic drug carriers and antibacterial agents

Publications (1)

Publication Number Publication Date
CA2954545A1 true CA2954545A1 (en) 2016-01-14

Family

ID=55064853

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2954545A Abandoned CA2954545A1 (en) 2014-07-08 2015-07-08 Amphiphilic peptide nanoparticles for use as hydrophobic drug carriers and antibacterial agents

Country Status (5)

Country Link
US (1) US20170202783A1 (enExample)
EP (1) EP3166643A4 (enExample)
JP (2) JP2017525676A (enExample)
CA (1) CA2954545A1 (enExample)
WO (1) WO2016007664A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
CN109701035A (zh) * 2017-10-26 2019-05-03 温州医科大学附属第二医院 一种新型乳腺癌分子诊断的荧光双亲肽自组装纳米胶束的制备工艺
CN119185557A (zh) 2018-04-06 2024-12-27 阿玛治疗公司 用于控释治疗剂的组合物
CN108752429B (zh) * 2018-06-22 2020-06-26 安徽工程大学 两亲性多肽p13及其制备方法
US20210315826A1 (en) * 2018-07-23 2021-10-14 Cornell University Natural fluorescent polydedral amino acid crystals for efficient entrapment and systemic delivery of hydrophobic small molecules
US20200222564A1 (en) * 2019-01-15 2020-07-16 Tianjin University Compound Amphiphilic Peptide Nanomicelle, Preparation and Use Thereof
CN109620801B (zh) * 2019-01-18 2021-05-14 天津大学 多模式治疗鼻咽癌的复合纳米胶束及其制备方法和应用
EP3942056A4 (en) * 2019-03-22 2022-12-21 Kansas State University Research Foundation LIPID INCLUDED AMPHIPATHIC PEPTIDES
CN110897161B (zh) * 2019-11-22 2022-10-28 华南理工大学 一种高荷载姜黄素的大豆多肽基纳米颗粒及其pH驱动制备方法与应用
CN113925841B (zh) * 2020-07-09 2022-12-30 中国科学技术大学 高载药效率纳米颗粒及其制备与应用
CN114306572A (zh) * 2022-01-06 2022-04-12 黑龙江八一农垦大学 转运抗菌肽的介孔纳米载体
WO2024004869A1 (ja) * 2022-06-29 2024-01-04 メスキュージェナシス株式会社 ペプチド及び該ペプチドを含む会合体又は組成物
JP2024012970A (ja) * 2022-07-19 2024-01-31 国立大学法人北海道大学 コンジュゲート並びにこれを用いた標的物質の表面特性の制御方法及び標的物質の回収方法
CN115919766B (zh) * 2022-12-27 2023-10-24 国科宁波生命与健康产业研究院 一种复合纳米胶束及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3272737A (en) * 1964-11-02 1966-09-13 Dow Chemical Co Separation of acids by dialysis with anion-exchange membranes
US9457056B2 (en) * 2007-12-04 2016-10-04 Ben-Gurion University Of The Negev Research And Development Authority Peptides comprising alternating hydrophobic and anionic amino acids for treatment of osteoporosis
CN101945887B (zh) * 2007-12-18 2015-08-19 新加坡科技研究局 阳离子核-壳肽纳米颗粒
US20100056485A1 (en) * 2008-08-28 2010-03-04 Snu R&Db Foundation Nanosoap containing silver nanoparticles
US20120003177A1 (en) * 2008-09-17 2012-01-05 Youqing Shen Curcumin-containing polymers and water-soluble curcumin derivatives as prodrugs of prodrug carriers
US8420077B2 (en) * 2009-04-20 2013-04-16 Allergan, Inc. Silk fibroin hydrogels and uses thereof
WO2011101859A1 (en) * 2010-02-22 2011-08-25 Institute Of Life Sciences A novel water soluble curcumin loaded nanoparticulate system for cancer therapy
US8795691B2 (en) * 2010-03-16 2014-08-05 Brown University Nanotubes and compositions thereof

Also Published As

Publication number Publication date
JP2017525676A (ja) 2017-09-07
EP3166643A1 (en) 2017-05-17
JP2020121977A (ja) 2020-08-13
US20170202783A1 (en) 2017-07-20
EP3166643A4 (en) 2018-03-07
WO2016007664A1 (en) 2016-01-14

Similar Documents

Publication Publication Date Title
US20170202783A1 (en) Amphiphilic Peptide Nanoparticles for Use as Hydrophobic Drug Carriers and Antibacterial Agents
Yang et al. Nanostructured antimicrobial peptides: crucial steps of overcoming the bottleneck for clinics
AU2018202074B2 (en) Pharmaceutical nanoparticles showing improved mucosal transport
AU2018361481B2 (en) Drug delivery systems and methods comprising polysialic acid and/or other polymers
Hu et al. pH-triggered charge-reversal silk sericin-based nanoparticles for enhanced cellular uptake and doxorubicin delivery
Thambi et al. Bioreducible polymersomes for intracellular dual-drug delivery
Yu et al. Research progress of natural silk fibroin and the application for drug delivery in chemotherapies
Wang et al. Nanodisk-based glioma-targeted drug delivery enabled by a stable glycopeptide
JP6214004B2 (ja) ナノ送達システム
Chen et al. Construction of surfactant-like tetra-tail amphiphilic peptide with RGD ligand for encapsulation of porphyrin for photodynamic therapy
JPH09508530A (ja) 核酸を含む組成物、その調製および使用
JP2013530993A (ja) 治療用コンジュゲートのための短く且つｄ−アミノ酸を含有するポリペプチドおよびその使用
US20130071482A1 (en) Block copolymer cross-linked nanoassemblies as modular delivery vehicles
Stepanova et al. Polypeptide-based systems: from synthesis to application in drug delivery
Priwitaningrum et al. Apoptosis-inducing peptide loaded in PLGA nanoparticles induces anti-tumor effects in vivo
WO2015168321A2 (en) Ocular compositions and methods thereof
He et al. An infection-microenvironment-targeted and responsive peptide-drug nanosystem for sepsis emergency by suppressing infection and inflammation
WO2023147596A1 (en) Triplex nanoparticles
Nam et al. Intracellular drug delivery using poly (d, l-lactide-co-glycolide) nano-particles derivatized with a peptide from a transcriptional activator protein of HIV-1
Solanki et al. Protein nanocarriers for the delivery of phytoconstituents
US20180236074A1 (en) Thermoresponsive bioconjugates and their controlled delivery of cargo
KR20240136673A (ko) 글리코콜산-고분자 접합체를 포함하는 자기조립 나노입자, 이의 제조방법 및 이를 포함하는 약물전달용 조성물
WO2012002715A2 (ko) 온도 민감성 생리활성 물질 전달체 및 이의 제조방법
Polat et al. Silk-based drug delivery systems: Advances, challenges, and future perspectives
Schneible A Material Toolbox for Advanced Therapeutics

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20220920